Researchers assessed the therapeutic equivalence of proposed biosimilar CT-P41 and reference denosumab for the treatment of postmenopausal osteoporosis.

A new study found that levothyroxine, a common medication for hypothyroidism sold as Synthroid, is linked to bone loss in ...

Millions of postmenopausal women find themselves facing a diagnosis of osteoporosis, but what does that mean for their daily ...

A REMS scan revealed Sarah had osteoporosis and osteopenia in her ... I wasn’t keen on taking alendronate tablets, the standard treatment to slow down bone loss. My mother takes them and they ...

Little is known about patients' long-term compliance with osteoporosis medications. In a US retrospective cohort study, Solomon et al. assessed the level and determinants of compliance with drugs ...

Methods. Data from the Medical Expenditure Panel Survey (MEPS) were used to estimate osteoporosis prevalence and treatment rates among individuals ages 50 years and older who self-reported having ...

“PPI use does not appear to be associated with osteoporosis or accelerated ... Although PPIs are considered to be safe and effective for the treatment of a number of conditions, several studies ...